作者
Vincent Law, Margi Baldwin, Ganesan Ramamoorthi, Krithika Kodumudi, Nam Tran, Inna Smalley, Derek Duckett, Pawel Kalinski, Brian Czerniecki, Keiran SM Smalley, Peter A Forsyth
发表日期
2021/1/29
期刊
JoVE (Journal of Visualized Experiments)
期号
167
页码范围
e62033
简介
Leptomeningeal disease (LMD) is an uncommon type of central nervous system (CNS) metastasis to the cerebral spinal fluid (CSF). The most common cancers that cause LMD are breast and lung cancers and melanoma. Patients diagnosed with LMD have a very poor prognosis and generally survive for only a few weeks or months. One possible reason for the lack of efficacy of systemic therapy against LMD is the failure to achieve therapeutically effective concentrations of drug in the CSF because of an intact and relatively impermeable blood-brain barrier (BBB) or blood-CSF barrier across the choroid plexus. Therefore, directly administering drugs intrathecally or intraventricularly may overcome these barriers. This group has developed a model that allows for the effective delivery of therapeutics (i.e., drugs, antibodies, and cellular therapies) chronically and the repeated sampling of CSF to determine drug …
引用总数
学术搜索中的文章
V Law, M Baldwin, G Ramamoorthi, K Kodumudi… - JoVE (Journal of Visualized Experiments), 2021